Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Pioglitazone Therapy'

The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receving treatment with metformin and pioglitazone and have inadequate glycemic (blood sugar) control.

本研究旨在对比两种不同剂量的卡格列净（canagliflozin）与安慰剂，针对接受二甲双胍（metformin）联合吡格列酮（pioglitazone）治疗且血糖（血液葡萄糖）控制不佳的2型糖尿病（type 2 diabetes mellitus）患者，评估其疗效与安全性。